Rhythm VC is a venture capital investment firm headquartered in New York, established in 2018. The firm specializes in investing in early-stage companies within the healthcare sector, focusing on those that adopt transformational approaches to meet significant unmet needs in the industry. By partnering with these innovative companies, Rhythm VC aims to support advancements that can lead to meaningful improvements in healthcare delivery and outcomes.
Sound Health uses acoustic resonance to provide nasal relief. Its current product is an app that scans the face to map the bone structure and then a headband that plays music at personalized frequencies for 10 minutes. The headband is off the shelf and the sound levels are akin to wearing earpods. It envisions the headband to be over-the-counter (OTC) so it’s easily accessible to patients, whether prescribed by doctors or not.
Sound Health
Seed Round in 2021
Sound Health uses acoustic resonance to provide nasal relief. Its current product is an app that scans the face to map the bone structure and then a headband that plays music at personalized frequencies for 10 minutes. The headband is off the shelf and the sound levels are akin to wearing earpods. It envisions the headband to be over-the-counter (OTC) so it’s easily accessible to patients, whether prescribed by doctors or not.
Parallel Health
Pre Seed Round in 2021
Powered by genomics, skin microbiome science, and machine learning, Parallel is an end-to-end next-generation skin health company providing derm telehealth, cutting-edge skin microbiome diagnostics, precision microbiome skincare, and personalized Rx
Aurie
Seed Round in 2021
Aurie is a medical device company based in New York, established in 2018. It focuses on developing a reusable urinary catheterization system aimed at improving the quality of life for individuals with disabilities. By providing a convenient, discreet, and hygienic catheterization option, Aurie seeks to reduce the risk of infections and enhance users' confidence and control over their healthcare needs. The company's innovative approach empowers users to manage their condition more effectively, enabling them to lead active and fulfilling lives.
Vital Bio
Seed Round in 2021
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.
Inflow
Pre Seed Round in 2021
Inflow is a company that specializes in developing a science-based digital program designed to assist individuals in managing attention deficit hyperactivity disorder (ADHD). Its mission is to empower those with ADHD by equipping them with essential skills and support needed to achieve their full potential. Inflow provides a cognitive behavioral therapy program that focuses on helping users understand the impact of ADHD, set personal goals, learn techniques to reduce procrastination, and track their progress. This comprehensive approach enables customers to better understand, manage, and treat their symptoms effectively.
Inherent Biosciences
Seed Round in 2021
Inherent Biosciences is a molecular diagnostics company focused on transforming the trial and error approach in medicine by leveraging insights from epigenetics. The company aims to provide clarity on complex health issues by identifying dysregulation across multiple genes and pathways, which informs personalized treatment strategies. Inherent Biosciences develops innovative therapies for a range of conditions, including pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, and COVID-19. By translating biological discoveries into actionable insights, the company seeks to enhance patient care and improve outcomes in various medical fields.
Parallel Health
Seed Round in 2021
Powered by genomics, skin microbiome science, and machine learning, Parallel is an end-to-end next-generation skin health company providing derm telehealth, cutting-edge skin microbiome diagnostics, precision microbiome skincare, and personalized Rx
RxDiet
Seed Round in 2021
RxDiet is a developer of a nutritional guidance platform that leverages artificial intelligence and automation to provide personalized meal solutions and health interventions. The company partners with national food retailers and leading health plans to deliver fresh groceries tailored to individual cultural and lifestyle preferences. This approach not only promotes a balanced diet but also aims to achieve exceptional clinical outcomes and cost savings for users. By integrating "food as medicine" principles, RxDiet addresses the growing demand for effective nutritional support in healthcare.
Aires Medical
Seed Round in 2020
Aires Medical, LLC is a medical device company based in Ann Arbor, Michigan, that develops innovative oxygen and ventilation support devices tailored for patients with chronic obstructive pulmonary disease (COPD). Founded in 2018, the company specializes in high-flow oxygen therapy and offers a miniature oxygen concentrator along with augmented ventilation solutions. Its products include a lightweight, wearable ventilator equipped with advanced technology that allows for oxygen production and filtration, significantly enhancing the quality of life for end-stage COPD patients. By focusing on creating effective and user-friendly devices, Aires Medical aims to eliminate the stigma associated with traditional home oxygen therapy and mechanical ventilation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.